The proof-of-concept study, co-led by McGill University researchers Dr. Matthew Dankner and Dr. Reza Forghani, alongside an international team of clinicians and scientists, demonstrated the AI model can detect the presence of cancer cells in surrounding brain tissue with 85-per-cent accuracy.
Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management,
Commencing in February 2025, the FORSEE (Forging Successful AI Applications for European Economy and Society) project is funded through the Beyond the horizon: A human-friendly deployment of artificial intelligence and related technologies funding call under the Horizon Europe programme.
The artificial intelligence–based model, dubbed SCORPIO, was developed by a team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and the Tisch Cancer Institute at Mount Sinai.